A European prospective observational study of enzalutamide (ENZA) in patients with metastatic castration-resistant prostate cancer (mCRPC): PREMISE
2015 ◽
Vol 33
(15_suppl)
◽
pp. e16054-e16054
2020 ◽
2015 ◽
Vol 51
◽
pp. S492
◽
2020 ◽
Vol 54
(2)
◽
pp. 115-121
◽